icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
eNq1mF1v2jAUhu/5FVEudkdCCm3pllBtrN2QWo3Rok27QSY5FDNjp/7go79+DqErnRyxGnyZOHnPsc/x41eOL1dz4i2AC8xo4kdBw/eApizD9CHxh/fX9bZ/2anFM7RAO5+dB40gOvG9lCAhEr8YDcaAqAh+3t58Bv0/cL9T82I2nkEqX32nJCbBVySmtygvvvHiBcOZNwc5ZVni50pu3nqxkFxn0Vky/lvkKIU43L7ZHZ2NWrvv47AQ+w9VJYDfIPpgFAVqpZkqzoHKLpLwwPi6It+mlTYWAxBM8RT6SE77nC1wBpkxxAQRAVZBJsvsDviCgCyCGMXDWToXVuJohlYDeOyZk/6oR7tyJeuNenTeOmtHjZNGFEVnVqH4zlKZq6AnEaaj6PS01Wo2Q6AhrAkgy8r0GZeIOKoJFt3XbeUoDofHvbXPsMgJWgczkdsuFeJIDwPXm9/dRIoZ3HONI6LX7B99qggJ35j1cAsLRxkXLOoyRWUFM64HtgvRZVTCqrqidpiTq20vYhDHk31i1Iz4vhoTnNoCTSNHgZDDQa+aZ8dDwSckYMjdseAHphlbiuMzZremjrLPN5g0iuY8i0YnF+0zXQbrLfRLN1DF6XKlOMsh1PTB4hCo9OiEHYoT3ZNmqeeOPFIzbhwOSxGBCo9Tt+SK7sJnS+asz93toXLAKPrl6t62Ob4r4Ou7zaNRGmfJ37LaQdcFyXUr7ku83LRJPmo2TtsXzdY7NM8/PJvnxNIol6JOfLLiZsJMpczF+zBcLpfBFIm6QHo9gwmv4v+lceLHmLyG7Ust3Rl5J0d/aYVK0DpKfVyeoG8rou223WcODjW82/+3xtoYQ3IFB9SiJLwzDveujo/2F7frLO3+K8C4C7NxpkhiRl15JjU2Kh52mOi60muuAfFtMsEVFyuVfRmH5aVOpxaHxYVOp/YHGu78sw==
2zBSG2msqHnVW72t
Listen
